Case report| Volume 27, ISSUE 6, P431-433, September 2005

Download started.


Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study


      We report an 11-year-old boy with apparently the motor axonal form of Guillain-Barre syndrome (GBS) who presented with severe paralysis and respiratory insufficiency by the 3rd day from onsets of symptoms. His serum anti-Mycoplasma pneumoniae and anti-Galactocerebroside (Gal-C) IgM antibody were significantly elevated. Magnetic resonance imaging, following contrast injection, showed enhancement of the cauda equina. The patient responded quickly and dramatically to immunoadsorption therapy using a tryptophan-immobilized column, with recovery of respiratory failure and muscle strength, dominantly in the left extremities. Immunoadsorption therapy should be considered for patients with anti Gal-C antibody-associated GBS.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hao Q.
        • Saida T.
        • Kuroki S.
        • Nishimura M.
        • Nukina M.
        • Obayashi H.
        • et al.
        Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections.
        J Neuroimmunol. 1998; 81: 116-126
        • French cooperative group on plasma exchange in Guillain-Barre syndrome
        Efficacy of plasma exchange in Guillain-Barre syndrome: role of replacement fluids.
        Ann Neurol. 1987; 22: 753-761
        • Haupt W.F.
        • Birkmann C.
        • Van der Ven C.
        • Pawlik G.
        Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barre syndrome.
        Ther Apher. 2000; 4: 198-200
        • Hirai K.
        • Kihara M.
        • Nakajima F.
        • Miyanomae Y.
        • Yoshioka H.
        Immunoadsorption therapy in Guillain-Barre syndrome.
        Pediatr Neurol. 1998; 19: 55-57
        • Kusunoki S.
        • Chiba A.
        • Hitoshi S.
        • Takizawa H.
        • Kanazawa I.
        Aniti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection.
        Muscle Nerve. 1995; 18: 409-413
        • Kusunoki S.
        • Shiina M.
        • Kanazawa I.
        Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.
        Neurology. 2001; 57: 736-738
        • Ilyas A.A.
        • Willison H.J.
        • Quarles R.H.
        • Jungalwala F.B.
        • Cornblath D.R.
        • Trapp B.D.
        • et al.
        Serum antibodies to gangliosides in Guillain-Barre syndrome.
        Ann Neurol. 1988; 23: 440-447
        • Okamiya S.
        • Ogino M.
        • Ogino Y.
        • Irie S.
        • Kanazawa N.
        • Saito T.
        • et al.
        Triptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome.
        Ther Apher. 2004; 8: 248-253
        • Crino P.B.
        • Zimmerman R.
        • Laskowitz D.
        • Raps E.C.
        • Rostami A.M.
        Magnetic resonance imaging of the cauda equina in Guillain-Barre syndrome.
        Neurology. 1994; 44: 1334-1336
        • Fuchigami T.
        • Iwata F.
        • Noguchi Y.
        • Kohira R.
        • Yamazaki H.
        • Okubo O.
        • et al.
        Magnetic resonance imaging of the cauda equina in two patients with Guillain-Barre syndrome.
        Acta Paediatr Jpn. 1997; 39: 607-610